Pure Global AI
NCT06349941Not yet recruiting

Telemedicine in Rural Patients With Heart Failure

Leveraging Telemedicine to Assess Care Quality and Improve Care Utilization Among Rural Patients With Heart Failure: The RURAL-HF Pilot Project
University of Texas Southwestern Medical CenterClinicalTrials.govdeviceDevice trial
Study focus
Disease/Condition
Heart Failure
Drug/Device/Intervention
Movn app
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
University of Texas Southwestern Medical Center
Timeline & enrollment
Phase
N/A
Start date
Jul 01, 2024
End date
Dec 01, 2024
Enrollment
100 participants
Primary outcome

Physical activity levels,Quality of life using KCCQ score

Summary

We propose a pilot trial examining the effectiveness of a mHealth-based home cardiac
 rehabilitation program using a telemedicine platform for the identification, recruitment, and
 retention of an underserved rural population with heart failure with reduced ejection
 fraction.(HFrEF). The goal of the pilot trial will be to demonstrate the feasibility of a
 telemedicine platform for the recruitment and retention of underserved rural patients in
 clinical trials. Participants will participate in a cardiac rehabilitation program delivered
 through a smartphone application called Movn. They will be monitored for 14 weeks.

ICD-10 classifications
Heart failureHeart failure, unspecifiedCongestive heart failureHypertensive heart disease with (congestive) heart failureLeft ventricular failure
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06349941
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06349941 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Texas Southwestern Medical Center and is currently Not yet recruiting. The study focuses on Heart Failure. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.